Kantoff Aaron Insider Trades

Insider Trading History

Track insider trading activity for Kantoff Aaron. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $87k 6,333 shares
Last Trade
Mar 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44k 3,166 shares
$13.89
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $43.5k 3,167 shares
Last Trade
Mar 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44k 3,166 shares
$13.89
$13.74
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $0 0 shares
Last Trade
Oct 28, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$806k 16,800 shares
$47.98
$47.98
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $0 0 shares
Last Trade
Oct 28, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$4.24M 88,281 shares
$48.00
$47.98
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $0 0 shares
Last Trade
Oct 28, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$480k 10,000 shares
$47.98
$47.98
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $4.24M 88,281 shares
Last Trade
Oct 24, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$240k 5,000 shares
$47.98
$47.98
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $4.48M 93,281 shares
Last Trade
Sep 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.28M 47,890 shares
$26.74
$47.98
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $0 0 shares
Last Trade
Sep 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.28M 47,890 shares
$26.74
$47.98
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $276k 20,100 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.8k 20,100 shares
$4.47
$13.74
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $806k 16,800 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315k 16,800 shares
$18.73
$47.98
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $87k 6,333 shares
Last Trade
Mar 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.8k 3,167 shares
$8.46
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $43.5k 3,167 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.8k 3,167 shares
$8.46
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $338k 24,600 shares
Last Trade
Aug 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 24,600 shares
$9.88
$13.74
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $480k 10,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 10,000 shares
$13.91
$47.98
Talaris Therapeutics
Talaris Therapeutics TALS
Director
Holding Value $123k 45,391 shares
Last Trade
Oct 24, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.4k 7,500 shares
$2.72
$2.72
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $2.18M 45,391 shares
Last Trade
Oct 24, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$89k 7,500 shares
$11.86
$47.98
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $480k 10,000 shares
Last Trade
Oct 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$94.6k 10,000 shares
$9.46
$47.98
Talaris Therapeutics
Talaris Therapeutics TALS
Director
Holding Value $27.2k 10,000 shares
Last Trade
Oct 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.2k 10,000 shares
$2.72
$2.72
Talaris Therapeutics
Talaris Therapeutics TALS
Director
Holding Value $103k 37,891 shares
Last Trade
Oct 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 37,890 shares
$2.72
$2.72
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $1.82M 37,890 shares
Last Trade
Oct 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.04M 37,890 shares
$27.40
$47.98

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up